 |
Ricin (blocked) conjugated murine monoclonal antibody (CD6) |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphomas, acute T-cell leukemia-lymphoma, and related mature T-cell malignancies |
| USA Market Approval | USA |
| USA Designation Date | 1994-09-06 00:00:00 |
| Sponsor | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 |
